Skip to main content
Year archive

Alphamab Oncology — 2020 filings

All 50 regulatory filings released by Alphamab Oncology (9966) in 2020, sourced directly from the official regulator.

50 Filings
2020 Period
2020 filings (50)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT
Regulatory Filings
2020-12-28 English
WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Regulatory Filings
2020-12-23 English
VOLUNTARY ANNOUNCEMENT - THE COMBINATION THERAPY OF KN026 AND KN046 WAS GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2020-12-23 English
VOLUNTARY ANNOUNCEMENT - BLA ACCEPTED BY THE NMPA FOR KN035 IN THE TREATMENT OF MSI-H/DMMR SOLID TUMORS
Regulatory Filings
2020-12-21 English
CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE AND TERMINATION OF THE ENGAGEMENT OF THE CHIEF FINANCIAL OFFICER AND THE BOARD SECRETARY
Regulatory Filings
2020-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Regulatory Filings
2020-12-04 English
Next Day Disclosure Return
Regulatory Filings
2020-11-17 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON PRELIMINARY POSITIVE RESULTS FROM THE COMBINATION THERAPY OF KN026 AND KN046 FOR POSTER PRESENTATION AT SITC 2020
Regulatory Filings
2020-11-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Regulatory Filings
2020-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Regulatory Filings
2020-10-08 English
2020 Interim Report
Regulatory Filings
2020-09-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Regulatory Filings
2020-09-04 English
VOLUNTARY ANNOUNCEMENT - KN046 WAS GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2020-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020
Regulatory Filings
2020-08-28 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Regulatory Filings
2020-08-06 English
CHANGE OF JOINT COMPANY SECRETARY AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Regulatory Filings
2020-07-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Regulatory Filings
2020-07-03 English
INSIDE INFORMATION ANNOUNCEMENT - COMPLETION OF PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
Regulatory Filings
2020-06-16 English
INSIDE INFORMATION ANNOUNCEMENT - PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER
Regulatory Filings
2020-06-12 English
VOLUNTARY ANNOUNCEMENT - CO-DEVELOPMENT OF ANTIBODY FOR CORONAVIRUS TREATMENT WITH INSTITUT PASTEUR OF SHANGHAI
Regulatory Filings
2020-06-10 English
VOLUNTARY ANNOUNCEMENT - STRATEGIC COLLABORATION WITH SANOFI ON KN026 IN HER2+ BREAST CANCER
Regulatory Filings
2020-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Regulatory Filings
2020-06-02 English
VOLUNTARY ANNOUNCEMENT - COLLABORATION AGREEMENT OF ANTI-TUMOR COMBINATION THERAPY WITH SLP
Regulatory Filings
2020-05-28 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON MAY 25, 2020
Regulatory Filings
2020-05-25 English
Next Day Disclosure Return
Regulatory Filings
2020-05-21 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON USING TRANSLATIONAL TGI MODEL AND POPULATION PK ANALYSIS FOR KN026 ACCEPTED FOR POSTER PRESENTATION AT 2020 AACR ANNUAL MEETING
Regulatory Filings
2020-05-18 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON PRELIMINARY RESULTS FROM CLINICAL TRIALS OF KN035 ACCEPTED FOR POSTER PRESENTATION AT 2020 ASCO ANNUAL MEETING
Regulatory Filings
2020-05-15 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON PRELIMINARY RESULTS FROM CLINICAL TRIALS OF KN026 AND KN046 ACCEPTED FOR POSTER PRESENTATION AT 2020 ASCO ANNUAL MEETING
Regulatory Filings
2020-05-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Regulatory Filings
2020-05-06 English
2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2020-04-22 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-04-21 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Regulatory Filings
2020-04-21 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES&#x3b; (2) PROPOSED ADOPTION OF POST-IPO SHARE OPTION SCHEME&#x3b; (3) PROPOSED RE-ELECTION OF THE RETIRING DIRECT
Regulatory Filings
2020-04-21 English
2019 Annual Report
Regulatory Filings
2020-04-21 English
VOLUNTARY ANNOUNCEMENT - JIANGSU ALPHAMAB RECEIVED THE SAFE TO PROCEED LETTER FROM THE U.S. FDA FOR A PHASE II CLINICAL TRIAL OF KN046 FOR NSCLC IN THE UNITED STATES
Regulatory Filings
2020-04-15 English
ADOPTION OF THE POST-IPO SHARE OPTION SCHEME
Regulatory Filings
2020-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Regulatory Filings
2020-04-03 English
CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT AGREEMENT WITH SUZHOU ALPHAMAB ON PROCESS OPTIMIZATION AND TRANSFER OF KN019, KN026 AND KN035 AND TECHNOLOGY DEVELOPMENT AGREEMENT WITH SUZH
Regulatory Filings
2020-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
Regulatory Filings
2020-03-31 English
INSIDE INFORMATION ANNOUNCEMENT - COLLABORATIVE AGREEMENT WITH SIMCERE PHARMACEUTICAL AND 3D MEDICINES FOR KN035 AND SUPPLEMENTAL AGREEMENTS TO THE KN035 CO-DEVELOPMENT AGREEMENT
Regulatory Filings
2020-03-30 English
VOLUNTARY ANNOUNCEMENT - COLLABORATION WITH PFIZER ON KN026 IN COMBINATION WITH IBRANCE(PALBOCICLIB) IN HER2+ BREAST CANCER
Regulatory Filings
2020-03-27 English
DATE OF BOARD MEETING
Regulatory Filings
2020-03-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Regulatory Filings
2020-03-04 English
VOLUNTARY ANNOUNCEMENT - FOUR IND APPLICATIONS ACCEPTED BY NMPA CDE FOR TWO ANTI-TUMOR BISEPECIFIC ANTIBODIES IN PIPELINE
Regulatory Filings
2020-02-20 English
VOLUNTARY ANNOUNCEMENT - JIANGSU ALPHAMAB PASSED ON-SITE INSPECTION OF EU QUALIFIED PERSON
Regulatory Filings
2020-02-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Regulatory Filings
2020-02-05 English
Next Day Disclosure Return
Regulatory Filings
2020-01-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
Regulatory Filings
2020-01-06 English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
Regulatory Filings
2020-01-05 English